News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Myriad Genetics, Inc. (MYGN) Elects Former Roche Molecular Systems, Inc. (RHHBF.PK) CEO Heiner Dreismann to Its Board of Directors


6/11/2010 10:33:28 AM

SALT LAKE CITY, June 10, 2010 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that it has elected Heiner Dreismann, Ph.D. to its Board of Directors, effective immediately, increasing the size of the Company's board from seven members to eight.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES